Coagulation Disorders Market, By Type (Hemophilia A, Hemophilia B, Von Willebrands Disease, and Factor II, V, X, XII Deficiencies), By Treatment, By Test, By End Users, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4458
|
Published Date
November 2025
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Coagulation Disorders Market size was valued at US$ 10,567.89 Million in 2024, expanding at a CAGR of 6.8% from 2025 to 2032.
The coagulation disorders market is being driven by the rising prevalence of bleeding and clotting disorders and advancements in personalized medicine, including gene therapies and recombinant clotting factors. The integration of artificial intelligence (AI) in diagnostics and disease management is enhancing the market by enabling predictive analytics, individualized treatment plans, and continuous patient monitoring, creating lucrative opportunities throughout the forecast period.
In addition, digital health solutions are improving patient convenience, enhancing treatment adherence, and delivering better outcomes through remote monitoring and telemedicine consultations. However, the market faces challenges such as supply chain disruptions, geographic disparities in healthcare infrastructure, high treatment costs, and regulatory hurdles. Slow adoption of novel testing technologies also acts as a restraint, potentially limiting the market’s growth in certain regions.
Coagulation Disorders Market- Market Dynamics
Growing Implementation of Gene Therapies and Personalized Medicine
Historically, hemophilia and other rare bleeding disorders have required repeated infusions of recombinant or plasma-derived clotting factors. While effective, these treatments are expensive, necessitate lifelong care, and carry the risk of inhibitor development. Gene therapies now offer the potential for one-time, long-lasting correction of coagulation factor deficiencies by introducing functional copies of defective genes. For example, in June 2023, the U.S. FDA approved gene therapies such as Roctavian (BioMarin) for Hemophilia A and Hemgenix (CSL Behring/UniQure) for Hemophilia B. Hemophilia A is a rare genetic disorder caused by a deficiency of clotting factor VIII (FVIII), leading to prolonged bleeding and potentially life-threatening complications, including uncontrolled internal bleeding and joint damage.
Personalized medicine further complements this shift by tailoring treatment plans to individual genetic profiles, enabling precise targeting of therapy while minimizing adverse effects. Advances in molecular diagnostics, including genetic testing and next-generation sequencing (NGS), support early diagnosis and patient stratification, improving outcomes by matching therapies to patient-specific characteristics.
Coagulation Disorders Market- Key Insights
- According to our research analyst’s analysis, the global coagulation disorders market is projected to grow at a CAGR of approximately 6.8% during the forecast period 2025–2032.
- Type Segmentation: Hemophilia A is expected to hold the largest market share in 2024.
- Treatment Segmentation: Blood transfusion is anticipated to be the leading treatment in 2024.
- Test Segmentation: The Prothrombin Time (PT) test is projected to be the most widely used diagnostic test in 2024.
- End-User Segmentation: Hospitals are expected to be the largest end-users in 2024.
- Regional Analysis: The Asia Pacific region is projected to be the leading revenue generator in 2024.
Coagulation Disorders Market- Segmentation Analysis:
The Global Coagulation Disorders Market is segmented on the basis of Type, Treatment, Test, End Users, and Region.
The market for coagulation disorders is divided into five types: Hemophilia A, Hemophilia B, Von Willebrand’s Disease (VWD), FactorII,V,X,XII deficiencies, and Others. HemophiliaA is a genetic disorder caused by a deficiency of clotting factorVIII; HemophiliaB involves a deficiency of factorIX, with similar bleeding symptoms. VonWillebrand’s Disease results from low or defective vonWillebrand factor, impairing plateletandclotting interactions and frequently causing mucosal bleeding. The group labelled FactorII,V,X,XII deficiencies covers rare coagulationfactor disorders affecting those specific factors, which lead to variable bleeding severity depending on the factor and level of deficiency.
In India, Hemophilia in general represents a substantial but underrecognised burden. India is estimated to have the world’s secondlargest population of haemophilia cases, with around 136,000 estimated cases of HemophiliaA alone. However, only a small fraction are formally registered: for example, only about 20,000–21,000 patients are registered, leaving an estimated 80% or more undiagnosed. These statistics underscore that while Hemophilia A and B dominate in awareness and numbers, the “Others” category of rarer factor deficiencies constitutes a diverse but much smaller segment of the bleedingdisorder market.
When divided by treatment modality, the market is categorised into Iron Supplementation, Blood Transfusion, and Others. Iron supplementation is chiefly used to address anaemia associated with chronic blood loss or haemorrhage from bleeding disorders, acting as a supportive therapy to maintain haemoglobin levels. Blood transfusion is used both to replace lost blood volume and to provide necessary clotting factors (via plasmaderived concentrates or fresh frozen plasma) in cases of active bleeding or major surgical intervention. The “Others” category covers more specialised treatments tailored to the type and severity of the disorder: factor replacement therapy (for example factorVIII for HemophiliaA, factorIX for HemophiliaB), desmopressin (especially in mild VWD cases), clotpreserving medications (antifibrinolytics), gene therapy and nonfactor therapies (such as bispecific antibodies) as emerging solutions. In India, while national guidelines exist, a significant gap remains in access to diagnosis and advanced therapies, leading to delayed treatment and higher complication rates.
Coagulation Disorders Market- Competitive Landscape:
The coagulation disorders market is highly competitive, driven by key global players focusing on innovation in therapies and diagnostic solutions. Leading companies are developing advanced treatment options, including gene therapies, long-acting recombinant clotting factors, monoclonal antibodies, and biosimilars, aimed at improving patient outcomes and quality of life. For example, in April 2024, Haemonetics Corporation received 510(k) clearance from the U.S. FDA for its TEG 6s hemostasis analyzer system’s Global Hemostasis-HN assay cartridge. This new cartridge expanded the system’s viscoelastic testing capabilities to include fully heparinized patients undergoing adult cardiovascular surgeries and liver transplantation.
Other key trends shaping the market include the adoption of plasma-free recombinant products and advancements in gene-editing technologies such as CRISPR. Companies are also investing in point-of-care diagnostics and wearable coagulation monitoring devices, driving a shift toward personalized and convenient patient care. Strategic collaborations, mergers, and acquisitions are common as companies aim to expand their product portfolios and regional presence.
Recent Developments:
- In July 2025, Bio-Rad Laboratories, Inc. launched four new Droplet Digital PCR (ddPCR) platforms, including the QX Continuum ddPCR system. Designed for translational research, the system features a simplified qPCR-like workflow, four-color multiplexing, and up to eight discrete thermal profiles per plate, expanding Bio-Rad’s presence in genomics research and applied sciences.
- In September 2025, VarmX B.V. partnered with CSL to develop VMX-C001, a treatment designed to restore coagulation in patients on FXa DOACs. The therapy is intended for single-dose infusion in emergency situations, such as severe bleeding or urgent surgery, where rapid restoration of clotting is critical.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL COAGULATION DISORDERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Griflos S.A
- Hoffman-La Roche Ltd
- Bio-Rad Laboratories
- B Braun
- Abbott
- Bayer AG
- Helena Laboratories
- Fresenius Kabi
- Haemonetics Corporation
- VarmX B.V.
- Biogen Inc.
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Hemophilia A
- Hemophilia B
- Von Willebrand’s Disease
- Factor II, V, X, XII Deficiencies
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
- Iron Supplementation
- Blood Transfusion
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032
- Complete Blood Count (CBC)
- Platelet Aggregation Test
- Fibrinogen Assay
- Prothrombin Time Test
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY END USERS- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Blood Banks
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Coagulation Disorders Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Coagulation Disorders Market Snippet by Type
2.1.2. Coagulation Disorders Market Snippet by Treatment
2.1.3. Coagulation Disorders Market Snippet by Test
2.1.4. Coagulation Disorders Market Snippet by End Users
2.1.5. Coagulation Disorders Market Snippet by Country
2.1.6. Coagulation Disorders Market Snippet by Region
2.2. Competitive Insights
3. Coagulation Disorders Key Market Trends
3.1. Coagulation Disorders Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Coagulation Disorders Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Coagulation Disorders Market Opportunities
3.4. Coagulation Disorders Market Future Trends
4. Coagulation Disorders Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Coagulation Disorders Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Coagulation Disorders Market Landscape
6.1. Coagulation Disorders Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Coagulation Disorders Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Hemophilia A
7.1.3. Hemophilia B
7.1.4. Von Willebrand’s Disease
7.1.5. Factor II, V, X, XII Deficiencies
7.1.6. Others
8. Coagulation Disorders Market – By Treatment
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment, 2024 & 2032 (%)
8.1.2. Iron Supplementation
8.1.3. Blood Transfusion
8.1.4. Others
9. Coagulation Disorders Market – By Test
9.1. Overview
9.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
9.1.2. Complete Blood Count (CBC)
9.1.3. Platelet Aggregation Test
9.1.4. Fibrinogen Assay
9.1.5. Prothrombin Time Test
9.1.6. Others
10. Coagulation Disorders Market – By End Users
10.1. Overview
10.1.1. Segment Share Analysis, By End Users, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Specialty Clinics
10.1.4. Diagnostic Centers
10.1.5. Blood Banks
10.1.6. Others
11. Coagulation Disorders Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Coagulation Disorders Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Coagulation Disorders Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Coagulation Disorders Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Coagulation Disorders Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Coagulation Disorders Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End Users, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Coagulation Disorders Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Griflos S.A
12.2.2. Hoffman-La Roche Ltd
12.2.3. Bio-Rad Laboratories
12.2.4. B Braun
12.2.5. Abbott
12.2.6. Bayer AG
12.2.7. Helena Laboratories
12.2.8. Fresenius Kabi
12.2.9. Haemonetics Corporation
12.2.10. VarmX B.V.
12.2.11. Biogen Inc.
12.2.12. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL COAGULATION DISORDERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Griflos S.A
- Hoffman-La Roche Ltd
- Bio-Rad Laboratories
- B Braun
- Abbott
- Bayer AG
- Helena Laboratories
- Fresenius Kabi
- Haemonetics Corporation
- VarmX B.V.
- Biogen Inc.
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Hemophilia A
- Hemophilia B
- Von Willebrand’s Disease
- Factor II, V, X, XII Deficiencies
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
- Iron Supplementation
- Blood Transfusion
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032
- Complete Blood Count (CBC)
- Platelet Aggregation Test
- Fibrinogen Assay
- Prothrombin Time Test
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY END USERS- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Blood Banks
- Others
GLOBAL COAGULATION DISORDERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
\"
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
